Companies in the Parkinson's disease industry
Parkinson's diseaseName | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Voyager Therapeutics is a biotechnology company founded in 2014 that is headquartered in Cambridge, Massachusetts developing gene therapies to treat neurological disorders. | ||||||
A company medicines for the treatmnet of neurological and endocrine based diseases and disorders | ||||||
Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics. | ||||||
Denali Therapeutics Inc. is a biotechnology company that focuses on the discovery and development of therapies for patients who are suffering from neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, ALS, and more. | ||||||
A biotech company using technology created at Johns Hopkins School of Medicine for the development of neuroprotective agents for neurologic disorders like Alzheimer’s disease and Parkinson’s disease. | ||||||
MISSION Therapeutics is a Cambridge, Cambridgeshire-based biotechnology company offering a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes. | ||||||
Vincere Biosciences is a company developing drugs to fight Parkinson’s disease and other age-related disorders. | ||||||
A biotechnology company that develops stem cell therapies for the treatment of neurodegenerative diseases | ||||||
Axial Therapeutics is a biopharmaceutical company targeting neurological disorders such as Parkinson's and Autism via gut health. | ||||||
Yumanity Therapeutics was launched in 2014 by Susan Lindquist and Tony Coles. The scientific co-founders with Lindquist were Vikram Khurana, Daniel Tardiff and Chee-Yeun Chung. | ||||||
Prevail Therapeutics is a New York City-based biotechnology company and a wholly owned subsidiary of Eli Lilly and Company. | ||||||
Convalesce is a company developing a stem cell based therapy for neurological conditions that leads to degeneration of neurons, like Parkinson's. | ||||||
Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders. | ||||||
D&D Pharmatech is a clinical-stage global biotech company that funds the development of revolutionary medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. | ||||||
vTv Therapeutics is a small molecules. | ||||||
Muna develops transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases | ||||||
Skyhawk Therapeutics is a RNA-correcting Small Molecules founded in 2016 by Bill Haney. | ||||||
Liftware is a stabilizing handle and a selection of attachments that include a soup spoon, everyday spoon, and fork. | ||||||
A biopharmaceutical company that develops therapies to treat Autism, neurological and other disorders | ||||||
OccamzRazor is an artificial Intelligence company founded in 2015 by Katharina Sophia Volz. | ||||||
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases | ||||||
Priavoid envisions curing neurological disorders by developing innovative treatment strategies based on a new class of orally available compounds. | ||||||
Melior Pharmaceuticals is a company identifying and developing small molecule therapeutics founded by Andrew G. Reaume. | ||||||
Company | ||||||
ReHaptix is a clinically validated mHealth application assisting patients and healthcare professionals in monitoring the rehabilitation progress of patients suffering from upper limb impairments caused by a neurological injury, such as stroke, multiple sclerosis or Parkinson's disease. |
